Oncotarget; the Oncology Medical Journal

Oncortarget is a reputable medical journal. Its content is derived from variety researches related to oncology. Oncology refers to a medical branch which deals with treatment, prevention, and diagnosis of cancer.

Oncotarget’s expedition

Oncortarget was first published in the year 2010. Its current publishers are Impact Journals. The publication is only available in the English language. Due to public demand, Oncotarget makes releases on a weekly basis.

The unique factor about this publication is it is an open access journal. Therefore anyone interested in Oncology news can read it online, financial, technical or legal barriers notwithstanding. The main editorial team is made up of two enthusiastic individuals, Mikhail Blagosklonny and Andrei V. Gudkov. Read more at dovepress.com.

Mikhail Blagoskylonny and his career in Oncology

Mikhail Blagosklonny is a famous scientist and professor who has spent a very great time of his life studying cancer and aging. He currently shares his knowledge and research findings with students at Rosewell Park Cancer Institute in New York

Mr. Blagoskylonny is a man of diverse knowledge and skills. He earned both his medical degree in Internal Medicine and Doctor of Philosophy in Medicine and Cardiology at the First Pavlov State Medical University of St. Peterburg. Mikhail’s skills enabled him to get appointed as the associate professor of Medicine at New York Medical College.

Before Mikhail became a professor, he worked as a senior scientist at Ordway Research Institute. Professor Blagoskylonny’s diverse research interest include cancer therapy and mechanisms of aging.

Mikhail’s advocacy in longevity research

Mikhail Blagoskylonny has conducted several types of research. He has come up with a hypothesis which highlights the possible role of TOR signaling in cancer and aging. He went ahead and proposed a popular cancer drug could cause full treatment and offer life extension.

Mikhail’s editorial ventures

Besides being a chief editor at Oncotarget, Mikhail Blagoskylonny is also editor in chief of Cell Cycle and Aging. Mikhail is as well an associate editor of Cancer Biology and Therapy. Cell Death and Differentiation editorial board also have Professor.

Blagoskylonny as an active member.

Professor Mikhail is a renowned author and has published over three hundred articles and journals related to Oncology.

Leave a Reply